NCT04198766 2025-12-18Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Inhibrx Biosciences, IncPhase 1/2 Active not recruiting296 enrolled
NCT05358548 2024-04-10ATATcH Alternating Treatment Plans for Advanced CancerRutgers, The State University of New JerseyPhase 2 Recruiting150 enrolled
NCT00703638 2017-11-29Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid TumorsMasonic Cancer Center, University of MinnesotaPhase 1 Completed16 enrolled
NCT01172028 2015-12-03Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsUniversity of ArizonaPhase 1 Completed33 enrolled